cystoscopy. cystoscopy
Conditions
Interventions
Intervention 1: Intervention group: Dexmedetomidine and ketamine: We inject 0.5 milligram in kilogram Ketamin and 1 milligram in kilogram of Dexmedetomidine. Intervention 2: Intervention group: The Fe
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Both sexes Age 18 to 65 years old ASA Class 1 and 2 Cystoscopy candidate No allergy to used drugs No history of cardio-pulmonary-liver and kidney disease Lack of Obstructive Sleep Apnea (OSA) No history of drug addiction or other psychotropic substances No history of acute drug or alcohol poisoning No history of psychological illness
Exclusion criteria
Exclusion criteria: Dissatisfaction to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of cystoscopy. Timepoint: After intervention. Method of measurement: hours.;Pain. Timepoint: Every 5 minutes to 60 minutes. Method of measurement: Visual analog scale.;Relaxation. Timepoint: Initially and after analgesia, and every 5 minutes during the procedure until 60 minutes later. Method of measurement: Ramsy score.;Satisfaction. Timepoint: After intervention. Method of measurement: questionnaire.;Mean arterial blood pressure. Timepoint: Every 5 minutes after the start of anesthesia until the end of the cystoscopy and during recovery. Method of measurement: mmHg.;Heart rate. Timepoint: Every 5 minutes after the start of anesthesia until the end of the cystoscopy and during recovery. Method of measurement: count. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Esmaeel Moshiri
Arak University of Medical Sciences
Outcome results
None listed